The verdict
Not shown to improve outcomes.
Evidence positions on IMSI (high-magnification sperm selection) from HFEA, ESHRE, NICE and ISAR| Body | Position |
|---|
| HFEA | - Grey — insufficient evidencefor chance of a baby
|
|---|
| ESHRE | Not for routine use Not recommended for routine clinical use. Source |
|---|
| NICE | Not addressed Not addressed in NG257. |
|---|
| ISAR | Needs robust RCTs Need robust RCTs to suggest use; very low-quality evidence in support. Source |
|---|
In India
Charged as an advanced-lab add-on, ~₹15,000–40,000 (varies; often bundled).
Last reviewed .